Iris Acquisition Holdings LLC - 30 Apr 2025 SCHEDULE 13D Report for Liminatus Pharma, Inc. Common Stock (LIMN)

Filing Manager
Iris Acquisition Holdings LLC
Reporting Manager
Iris Acquisition Holdings LLC
Security
Liminatus Pharma, Inc. Common Stock
Symbol
LIMN
Shares outstanding
26,037,736 shares
Disclosed Ownership
6,900,000 shares
Ownership
26%
Form type
SCHEDULE 13D
Filing time
08 May 2025, 16:21:49 UTC
Date of event
30 Apr 2025
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Iris Acquisition Holdings LLC 26% 6,900,000 6,900,000 0 /s/ Sumit Mehta Sumit Mehta, Authorized Representative 0002064461